Bronchial asthma and Chlamydia pneumoniae antibodies in children aged 4-8 years in Olomouc district
Related Experiment Video
Updated: Mar 2, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Frantisek Kopriva1, Jaroslava Szotkowská, Martin Zápalka
1Department of Pediatrics, Palacky University, Olomouc, Czech Republic. Koprivaf@fnol.cz
Insights
Chlamydia pneumoniae infection is linked to asthma in children. This study found higher IgM and IgG antibody levels in atopic children with asthma, suggesting a connection between infection and pediatric asthma.
Area of Science:
- Pediatric Allergy and Immunology
- Infectious Diseases
Background:
- Previous research linked Chlamydia pneumoniae infection to asthma exacerbations in adults.
- Limited data exists on C. pneumoniae's role in childhood asthma development.
Purpose of the Study:
- To investigate the association between C. pneumoniae infection and asthma in atopic children.
- To compare infection markers in children with chronic cough and asthma versus non-atopic controls.
Main Methods:
- Serological detection of C. pneumoniae-specific IgM, IgG, and IgA antibodies.
- Utilized Chlamydien-rELISA kits for antibody quantification.
Main Results:
- Elevated IgM and IgG antibodies to C. pneumoniae were found in 44% of children with asthma.
- 24% of atopic children with chronic cough showed positive antibodies.
- 16% of non-atopic controls had detectable C. pneumoniae antibodies.
Conclusions:
- Childhood asthma shows a significant association with elevated IgM and IgG antibodies to C. pneumoniae.
- C. pneumoniae infection may play a role in the pathogenesis of pediatric asthma.
Background:
Although several studies have demonstrated an association between infection with Chlamydia pneumoniae and asthma, these were mainly limited to exacerbation of symptoms in adults with known asthma
Objective:
We investigated the role of C. pneumoniae infection in 149 atopic children with chronic cough and asthma, comparing them with 241 control non-atopic subjects presenting at Olomouc hospital between 1999 and 2003 with non-specific symptoms (temperature above normal (subfebrile), abdominal pain, arthralgia, and other symptoms.
Methods:
The levels of C. pneumoniae-specific antibodies were measured using Chlamydien-rELISA kits (Medac, Hamburg, Germany).
Results:
In a group of 83 atopic children with chronic cough, IgM and IgG antibodies to C. pneumoniae were demonstrated in 20 children (24 %). Among children with bronchial asthma, positive antibody was present in 29 children (44 %; /p = 0,052/); of this number, 24 (36 %; /p = 0,06/) had IgM and IgG antibodies while 5 children (8 %) had IgA and IgG antibodies against C. pneumoniae. A group of non-atopic children with non-specific symptoms included 38 children (16 %) with antibody positivity; 27 children (11 %) with IgM and IgG antibodies and 11 children (5 %) with IgA and IgG antibodies against C. pneumoniae.
Conclusions:
Asthma in children was associated with elevated levels of IgM and IgG antibodies to C. pneumoniae.
More Related Videos
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Pneumonia III: Complications and Assessment

